Photys Therapeutics

Photys Therapeutics

Biotechnology

Waltham, MA 1,951 followers

Developing novel bifunctional medicines for fine-tuned control of protein post-translational modifications

About us

Photys Therapeutics’ proprietary bifunctional small molecules platform unlocks fine-tuned control of protein post-translational modifications, going beyond degradation to restore protein function, repair signaling, and amplify endogenous disease-fighting mechanisms. Photys was co-founded by the Broad Institute’s leading bifunctional chemist, Amit Choudhary, and the Longwood Fund, alongside a scientific advisory board comprised of distinguished scientists and drug developers – MIT’s Angela Koehler, Salk’s Tony Hunter, Berkeley’s Dan Nomura, MPM’s Wendy Young, and Dana Farber’s Eric Fischer.

Website
https://photys.com
Industry
Biotechnology
Company size
11-50 employees
Headquarters
Waltham, MA
Type
Privately Held
Founded
2021

Locations

Employees at Photys Therapeutics

Updates

Similar pages

Browse jobs

Funding